Geri-Med Oy

Helsinki 00180

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Coronary Heart Disease (CHD)

Studies at this site

• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early